Prognostic implication of erector spinae muscles in non-small-cell lung cancer patients treated with immuno-oncology combinatorial chemotherapy.

Taisuke ArakiYoshiaki KitaguchiYusuke SuzukiMasamichi KomatsuKei SoneharaYosuke WadaKazunari TateishiMasayuki Hanaoka

Published in: Thoracic cancer (2021)

The results of this study indicate that the pretreatment ESMCSA /BSA may be a potential prognostic factor in NSCLC patients receiving first-line IO-chemotherapy.

Keyphrases

prognostic factors
ultrasound guided
pain management
locally advanced
small cell lung cancer
radiation therapy
chemotherapy induced
chronic pain
risk assessment
epidermal growth factor receptor